Enable job alerts via email!
Boost your interview chances
A leading global biopharmaceutical company is seeking a Senior Director of Regulatory Affairs in Palo Alto. This role will lead US regulatory strategies, managing submissions and working closely with multiple functions to drive compliance and expedite drug development. The ideal candidate will exhibit exceptional leadership, regulatory expertise, and the ability to navigate complex regulatory landscapes.
Join to apply for the Senior Director, Regulatory Affairs - Job ID: SDRA role at TieTalent
1 day ago Be among the first 25 applicants
Join to apply for the Senior Director, Regulatory Affairs - Job ID: SDRA role at TieTalent
About
Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with locations in Denmark, Europe, and the United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology.
About
Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with locations in Denmark, Europe, and the United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology.
The Sr. Director, Regulatory Affairs will serve as the therapeutic area head for assigned products and lead the US RA Strategy team. This role involves managing regulatory submissions and providing strategic leadership to ensure the successful design and execution of non-clinical and clinical trials as well as Life Cycle Management Strategies. The Sr. Director will work closely with the executive team to formulate strategies, enhance performance, implement relevant policies, and provide key insights that enable the organization to operate collaboratively and proactively. This role involves engaging closely with internal peers and externally stakeholders such as the FDA, EMA, and other key regulatory bodies. The candidate must not only be adept at formulating and driving strategy, but also be tactically oriented, an exceptional leader with strong people management skills and playing a hands-on role in regulatory.
The ideal candidate will have a proven ability to partner effectively with multiple functions, including Clinical development, Research, Product Development, Medical Affairs, Commercial and Quality. Strong interpersonal skills are essential, as this individual will serve as a trusted voice within the company. The candidate must demonstrate outstanding leadership and management skills, rigorous scientific intellect, and an understanding of the business aspects of drug development.
At a personal level, the company is seeking a highly motivated individual who thrives on being challenged and working in highly collaborative environments to contribute to their cutting-edge science.
This position requires a high level of energy, focus, and a passion and sense of urgency for developing important new medicines for devastating diseases. This position will report to the VP, Regulatory Affairs and ideally be based in the Ascendis Pharma corporate offices in Palo Alto, CA or Princeton, NJ.
TAH for assigned product and Head of US RA. Phrase it as you deem fit but make it clear that this is a dual role, somewhere within the Position Summary section of the JD.
Key Responsibilities
Referrals increase your chances of interviewing at TieTalent by 2x
Palo Alto, CA $225,000.00-$240,000.00 2 weeks ago
San Francisco Bay Area $265,000.00-$290,000.00 2 weeks ago
Brisbane, CA $265,000.00-$295,000.00 2 weeks ago
Hayward, CA $265,000.00-$295,000.00 2 weeks ago
Brisbane, CA $265,000.00-$295,000.00 1 day ago
Alameda, CA $193,300.00-$386,700.00 1 day ago
Hayward, CA $265,000.00-$295,000.00 1 day ago
Brisbane, CA $253,400.00-$313,000.00 2 weeks ago
Alameda, CA $167,500.00-$237,500.00 1 week ago
Foster City, CA $210,375.00-$272,250.00 2 weeks ago
Redwood City, CA $240,000.00-$275,000.00 2 weeks ago
San Mateo, CA $260,000.00-$285,000.00 1 week ago
South San Francisco, CA $260,687.00-$322,025.00 1 month ago
South San Francisco, CA $148,400.00-$162,400.00 3 weeks ago
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.